REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/06/2026
Back to search
Official data from USPTO
RX OURPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
07/06/2026
Trademark type
Combined
Nice classes
40
Filing date
04/05/2018
Registration date
07/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/06/2021
Last transaction
07/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/07/2020
First use in commerce
04/07/2020
Drawing code
3
Owner type
16
Owner location
Rogers, AR, US
Examiner
CAPSHAW, DANIEL
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "OURPHARMA" in stylized format having the letters "Rx" encircled with the "O" in stylized format.
Holders and representatives
Holders
OURPHARMA, LLC
OURPHARMA, LLC
Representatives
Adam Hopkins ROSE LAW FIRM
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacture of drugs by pharmaceutical compounders
Publications
History of USPTO decisions and trademark events.
54 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/14/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/14/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/03/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/25/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/25/2021
ALIE
ASSIGNED TO LIE
05/25/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/17/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/17/2020
GNRT
NON-FINAL ACTION E-MAILED
11/17/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/17/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/03/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/03/2020
IUAF
USE AMENDMENT FILED
10/21/2020
EISU
TEAS STATEMENT OF USE RECEIVED
10/21/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/16/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/16/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/16/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/16/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/24/2020
EX3G
SOU EXTENSION 3 GRANTED
03/20/2020
EXT3
SOU EXTENSION 3 FILED
03/20/2020
EEXT
SOU TEAS EXTENSION RECEIVED
03/20/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/04/2019
EX2G
SOU EXTENSION 2 GRANTED
10/02/2019
EXT2
SOU EXTENSION 2 FILED
10/02/2019
EEXT
SOU TEAS EXTENSION RECEIVED
10/02/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/13/2019
EX1G
SOU EXTENSION 1 GRANTED
04/11/2019
EXT1
SOU EXTENSION 1 FILED
04/11/2019
EEXT
SOU TEAS EXTENSION RECEIVED
04/11/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/06/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/11/2018
PUBO
PUBLISHED FOR OPPOSITION
09/11/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/22/2018
ALIE
ASSIGNED TO LIE
08/09/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/27/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/26/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/25/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/24/2018
GNRT
NON-FINAL ACTION E-MAILED
07/24/2018
CNRT
NON-FINAL ACTION WRITTEN
07/24/2018
DOCK
ASSIGNED TO EXAMINER
07/24/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/14/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2018
NWAP
NEW APPLICATION ENTERED
04/09/2018
Continuous trademark protection
Get notified about every new filing that threatens RX OURPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.